Vascular endothelial growth factor in cerebral ischemia

Journal of Neuroscience Research

Volumn 89, Issue 7, 2011, Pages 969-978

  Ma, Yihui ^a   Qu, Yan ^a   Fei, Zhou ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Neurogenesis; Neuroprotection; Stroke; VEGF

Indexed keywords

ANGIOPOIETIN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; BRAIN ISCHEMIA; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; BRAIN EDEMA; BRAIN ISCHEMIA; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NEUROGENESIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79955623913     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22628     Document Type: Review

References (93)

1. Abumiya T, Yokota C, Kuge Y, Minematsu K. 2005. Aggravation of hemorrhagic transformation by early intraarterial infusion of low-dose vascular endothelial growth factor after transient focal cerebral ischemia in rats. Brain Res 1049: 95-103.
2. Argaw AT, Gurfein BT, Zhang Y, Zameer A, John GR. 2009. VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown. Proc Natl Acad Sci U S A 106: 1977-1882.
3. Beck H, Plate KH. 2009. Angiogenesis after cerebral ischemia. Acta Neuropathol 117: 481-496.
4. Bellomo M, Adamo EB, Deodato B, Catania MA, Mannucci C, Marini H, Marciano MC, Marini R, Sapienza S, Giacca M, Caputi AP, Squadrito F, Calapai G. 2003. Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil. Pharmacol Res 48: 309-317.
5. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y. 2001. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 98: 6390-6395.
6. Carmeliet P. 2003. Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet 4: 710-720.
7. Chen H, Chedotal A, He Z, Goodman CS, Tessier-Lavigne M. 1997. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 19: 547-559.
8. Chi OZ, Hunter C, Liu X, Weiss HR. 2007. Effects of anti-VEGF antibody on blood-brain barrier disruption in focal cerebral ischemia. Exp Neurol 204: 283-287.
9. Chiba Y, Sasayama T, Miyake S, Koyama J, Kondoh T, Hosoda K, Kohmura E. 2008. Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia. Kobe J Med Sci 54: E136-E146.
10. Chu K, Park KI, Lee ST, Jung KH, Ko SY, Kang L, Sinn DI, Lee YS, Kim SU, Kim M, Roh JK. 2005. Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia. Neurosci Res 53: 384-390.
11. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA. 1999. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4: 915-924.
12. Ferrara N. 2010. Pathways mediating VEGF-independent tumor angiogenesis. Cytokine Growth Factor Rev 21: 21-26.
13. Ferrara N, Gerber HP, LeCouter J. 2003. The biology of VEGF and its receptors. Nat Med 9: 669-676.
14. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
15. Fujita H, Zhang B, Sato K, Tanaka J, Sakanaka M. 2001. Expressions of neuropilin-1, neuropilin-2 and semaphorin 3A mRNA in the rat brain after middle cerebral artery occlusion. Brain Res 914: 1-14.
16. Gao P, Shen F, Gabriel RA, Law D, Yang E, Yang GY, Young WL, Su H. 2009. Attenuation of brain response to vascular endothelial growth factor-mediated angiogenesis and neurogenesis in aged mice. Stroke 40: 3596-3600.
17. Geretti E, Shimizu A, Klagsbrun M. 2008. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 11: 31-39.
18. Ha CH, Jin ZG. 2009. Protein kinase D1, a new molecular player in VEGF signaling and angiogenesis. Mol Cells 28: 1-5.
19. Hai J, Li ST, Lin Q, Pan QG, Gao F, Ding MX. 2003. Vascular endothelial growth factor expression and angiogenesis induced by chronic cerebral hypoperfusion in rat brain. Neurosurgery 53: 963-970; discussion 970-972.
20. Harrigan MR, Ennis SR, Masada T, Keep RF. 2002. Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery 50: 589-598.
21. Harrigan MR, Ennis SR, Sullivan SE, Keep RF. 2003. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. Acta Neurochir 145: 49-53.
22. Hayashi T, Abe K, Itoyama Y. 1998. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 18: 887-895.
23. He Z, Tessier-Lavigne M. 1997. Neuropilin is a receptor for the axonal chemorepellent semaphorin III. Cell 90: 739-751.
24. Hermann DM, Zechariah A. 2009. Implications of vascular endothelial growth factor for postischemic neurovascular remodeling. J Cereb Blood Flow Metab 29: 1620-1643.
25. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. 1992. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267: 26031-26037.
26. Issbrucker K, Marti HH, Hippenstiel S, Springmann G, Voswinckel R, Gaumann A, Breier G, Drexler HC, Suttorp N, Clauss M. 2003. p38 MAP kinase-a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J 17: 262-264.
27. Jin KL, Mao XO, Greenberg DA. 2000. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A 97: 10242-10247.
28. Jin K, Mao XO, Batteur SP, McEachron E, Leahy A, Greenberg DA. 2001a. Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience 108: 351-38.
29. Jin K, Minami M, Lan JQ, Mao XO, Batteur S, Simon RP, Greenberg DA. 2001b. Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat. Proc Natl Acad Sci U S A 98: 4710-4715.
30. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. 2002. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A 99: 11946-11950.
31. Jin K, Wang X, Xie L, Mao XO, Zhu W, Wang Y, Shen J, Mao Y, Banwait S, Greenberg DA. 2006. Evidence for stroke-induced neurogenesis in the human brain. Proc Natl Acad Sci U S A 103: 13198-13202.
32. Kawamura H, Li X, Goishi K, van Meeteren LA, Jakobsson L, Cebe-Suarez S, Shimizu A, Edholm D, Ballmer-Hofer K, Kjellen L, Klagsbrun M, Claesson-Welsh L. 2008. Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood 112: 3638-3649.
33. Kaya D, Gursoy-Ozdemir Y, Yemisci M, Tuncer N, Aktan S, Dalkara T. 2005. VEGF protects brain against focal ischemia without increasing blood-brain permeability when administered intracerebroventricularly. J Cereb Blood Flow Metab 25: 1111-1118.
34. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. 1989. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246: 1309-1312.
35. Kilic E, Kilic U, Wang Y, Bassetti CL, Marti HH, Hermann DM. 2006a. The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood-brain barrier permeability after focal cerebral ischemia. FASEB J 20: 1185-1187.
36. Kilic U, Kilic E, Jarve A, Guo Z, Spudich A, Bieber K, Barzena U, Bassetti CL, Marti HH, Hermann DM. 2006b. Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J Neurosci 26: 12439-12446.
37. Kimura R, Nakase H, Tamaki R, Sakaki T. 2005. Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction. Stroke 36: 1259-1263.
38. Koyama J, Miyake S, Sasayama T, Chiba Y, Kondoh T, Kohmura E. 2010. The novel VEGF receptor antagonist, VGA1155, reduces edema, decreases infarct and improves neurological function after stroke in rats. Kobe J Med Sci 56: E1-E11.
39. Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM. 1994. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 25: 1794-1798.
40. Kumai Y, Ooboshi H, Ibayashi S, Ishikawa E, Sugimori H, Kamouchi M, Kitazono T, Egashira K, Iida M. 2007. Postischemic gene transfer of soluble Flt-1 protects against brain ischemia with marked attenuation of blood-brain barrier permeability. J Cereb Blood Flow Metab 27: 1152-1160.
41. Lee HT, Chang YC, Tu YF, Huang CC. 2009. VEGF-A/VEGFR-2 signaling leading to cAMP response element-binding protein phosphorylation is a shared pathway underlying the protective effect of preconditioning on neurons and endothelial cells. J Neurosci 29: 4356-4368.
42. Lee HT, Chang YC, Tu YF, Huang CC. 2010. CREB activation mediates VEGF-A's protection of neurons and cerebral vascular endothelial cells. J Neurochem 113: 79-91.
43. Lennmyr F, Ata KA, Funa K, Olsson Y, Terent A. 1998. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. J Neuropathol Exp Neurol 57: 874-882.
44. Lennmyr F, Terent A, Syvanen AC, Barbany G. 2005. Vascular endothelial growth factor gene expression in middle cerebral artery occlusion in the rat. Acta Anaesthesiol Scand 49: 488-493.
45. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
46. Li SF, Sun YB, Meng QH, Li SR, Yao WC, Hu GJ, Li ZJ, Wang RZ. 2009. Recombinant adeno-associated virus serotype 1-vascular endothelial growth factor promotes neurogenesis and neuromigration in the subventricular zone and rescues neuronal function in ischemic rats. Neurosurgery 65: 771-779; discussion 779.
47. Maiese K, Boniece I, DeMeo D, Wagner JA. 1993. Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity. J Neurosci 13: 3034-3040.
48. Manoonkitiwongsa PS, Schultz RL, McCreery DB, Whitter EF, Lyden PD. 2004. Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis. J Cereb Blood Flow Metab 24: 693-702.
49. Marti HH, Risau W. 1998. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci U S A 95: 15809-15814.
50. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E, Risau W. 2000. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol 156: 965-976.
51. Mayhan WG. 1999. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am J Physiol 276: C1148-C1153.
52. Miki Y, Nonoguchi N, Ikeda N, Coffin RS, Kuroiwa T, Miyatake S. 2007. Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia. Neurosurgery 61: 586-594; discussion 594-595.
53. Monacci WT, Merrill MJ, Oldfield EH. 1993. Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am J Physiol 264: C995-C1002.
54. Morbidelli L, Pyriochou A, Filippi S, Vasileiadis I, Roussos C, Zhou Z, Loutrari H, Waltenberger J, Stossel A, Giannis A, Ziche M, Papapetropoulos A. 2010. The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability. Am J Physiol Regul Integr Comp Physiol 298: R824-R832.
55. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. 1999. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9-22.
56. Nor JE, Christensen J, Mooney DJ, Polverini PJ. 1999. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154: 375-384.
57. Park JE, Keller GA, Ferrara N. 1993. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 4: 1317-1326.
58. Paul R, Zhang ZG, Eliceiri BP, Jiang Q, Boccia AD, Zhang RL, Chopp M, Cheresh DA. 2001. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 7: 222-227.
59. Plaschke K, Staub J, Ernst E, Marti HH. 2008. VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion. Exp Neurol 214: 285-292.
60. Ploughman M, Windle V, MacLellan CL, White N, Dore JJ, Corbett D. 2009. Brain-derived neurotrophic factor contributes to recovery of skilled reaching after focal ischemia in rats. Stroke 40: 1490-1495.
61. Qin L, Zeng H, Zhao D. 2006. Requirement of protein kinase D tyrosine phosphorylation for VEGF-A165-induced angiogenesis through its interaction and regulation of phospholipase Cgamma phosphorylation. J Biol Chem 281: 32550-32558.
62. Roskoski RJr. 2008. VEGF receptor protein-tyrosine kinases: structure and regulation. Biochem Biophys Res Commun 375: 287-291.
63. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. 1983. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983-985.
64. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.
65. Shen F, Su H, Fan Y, Chen Y, Zhu Y, Liu W, Young WL, Yang GY. 2006. Adeno-associated viral-vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice. Stroke 37: 2601-2606.
66. Shin YJ, Choi JS, Lee JY, Choi JY, Cha JH, Chun MH, Lee MY. 2008. Differential regulation of vascular endothelial growth factor-C and its receptor in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol 116: 517-527.
67. Shin YJ, Choi JS, Choi JY, Cha JH, Chun MH, Lee MY. 2010. Enhanced expression of vascular endothelial growth factor receptor-3 in the subventricular zone of stroke-lesioned rats. Neurosci Lett 469: 194-198.
68. Shraga-Heled N, Kessler O, Prahst C, Kroll J, Augustin H, Neufeld G. 2007. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. FASEB J 21: 915-926.
69. Stowe AM, Plautz EJ, Eisner-Janowicz I, Frost SB, Barbay S, Zoubina EV, Dancause N, Taylor MD, Nudo RJ. 2007. VEGF protein associates to neurons in remote regions following cortical infarct. J Cereb Blood Flow Metab 27: 76-85.
70. Stowe AM, Plautz EJ, Nguyen P, Frost SB, Eisner-Janowicz I, Barbay S, Dancause N, Sensarma A, Taylor MD, Zoubina EV, Nudo RJ. 2008. Neuronal HIF-1 alpha protein and VEGFR-2 immunoreactivity in functionally related motor areas following a focal M1 infarct. J Cereb Blood Flow Metab 28: 612-620.
71. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA. 2003. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111: 1843-1851.
72. Sun Y, Jin K, Childs JT, Xie L, Mao XO, Greenberg DA. 2006. Vascular endothelial growth factor-B (VEGFB) stimulates neurogenesis: evidence from knockout mice and growth factor administration. Dev Biol 289: 329-335.
73. Taoufik E, Petit E, Divoux D, Tseveleki V, Mengozzi M, Roberts ML, Valable S, Ghezzi P, Quackenbush J, Brines M, Cerami A, Probert L. 2008. TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury. Proc Natl Acad Sci U S A 105: 6185-6190.
74. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266: 11947-11954.
75. Udo H, Yoshida Y, Kino T, Ohnuki K, Mizunoya W, Mukuda T, Sugiyama H. 2008. Enhanced adult neurogenesis and angiogenesis and altered affective behaviors in mice overexpressing vascular endothelial growth factor 120. J Neurosci 28: 14522-14536.
76. van Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, Tumas D, Gerlai R, Williams SP, van Lookeren Campagne M, Ferrara N. 1999. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 104: 1613-1620.
77. Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG, Stacker SA, Alitalo K. 2001. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20: 1223-1231.
78. Vogel C, Bauer A, Wiesnet M, Preissner KT, Schaper W, Marti HH, Fischer S. 2007. Flt-1, but not Flk-1 mediates hyperpermeability through activation of the PI3-K/Akt pathway. J Cell Physiol 212: 236-243.
79. Wang T, Soker S, Atala A, Siroky MB, Azadzoi KM. 2004. Alterations in angiogenic growth factors and neuronal nitric oxide synthase expression in chronic cavernosal ischemia. Int J Impot Res 16: 403-411.
80. Wang Y, Kilic E, Kilic U, Weber B, Bassetti CL, Marti HH, Hermann DM. 2005. VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128: 52-163.
81. Wang Y, Jin K, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA. 2007a. VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration. J Neurosci Res 85: 740-747.
82. Wang YQ, Guo X, Qiu MH, Feng XY, Sun FY. 2007b. VEGF overexpression enhances striatal neurogenesis in brain of adult rat after a transient middle cerebral artery occlusion. J Neurosci Res 85: 73-82.
83. Wang YQ, Cui HR, Yang SZ, Sun HP, Qiu MH, Feng XY, Sun FY. 2009. VEGF enhance cortical newborn neurons and their neurite development in adult rat brain after cerebral ischemia. Neurochem Int 55: 629-636.
84. Wittko IM, Schanzer A, Kuzmichev A, Schneider FT, Shibuya M, Raab S, Plate KH. 2009. VEGFR-1 regulates adult olfactory bulb neurogenesis and migration of neural progenitors in the rostral migratory stream in vivo. J Neurosci 29: 8704-8714.
85. Wong C, Jin ZG. 2005. Protein kinase C-dependent protein kinase D activation modulates ERK signal pathway and endothelial cell proliferation by vascular endothelial growth factor. J Biol Chem 280: 33262-33269.
86. Yano A, Shingo T, Takeuchi A, Yasuhara T, Kobayashi K, Takahashi K, Muraoka K, Matsui T, Miyoshi Y, Hamada H, Date I. 2005. Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia. J Neurosurg 103: 104-114.
87. Zachary I. 2005. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential. Neurosignals 14: 207-221.
88. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, Powers C, Bruggen N, Chopp M. 2000. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106: 829-838.
89. Zhang ZG, Tsang W, Zhang L, Powers C, Chopp M. 2001. Up-regulation of neuropilin-1 in neovasculature after focal cerebral ischemia in the adult rat. J Cereb Blood Flow Metab 21: 541-549.
90. Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M. 2002. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab 22: 379-392.
91. Zhao Y, Li Z, Wang R, Wei J, Li G, Zhao H. 2010. Angiopoietin 1 counteracts vascular endothelial growth factor-induced blood-brain barrier permeability and alleviates ischemic injury in the early stages of transient focal cerebral ischemia in rats. Neurol Res 32: 748-755.
92. Zhu Y, Jin K, Mao XO, Greenberg DA. 2003. Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression. FASEB J 17: 186-193.
93. Zhu Y, Lee C, Shen F, Du R, Young WL, Yang GY. 2005. Angiopoietin-2 facilitates vascular endothelial growth factor-induced angiogenesis in the mature mouse brain. Stroke 36: 1533-1537.